TFF Pharmaceuticals, Inc. revenue breakdown overview

TFF Pharmaceuticals, Inc. revenue for the last year amounted to 733.87 k USD, the most of which — 733.87 k USD — came from its highest performing source at the moment, Inhaled Dry Powder Drugs, the year earlier bringing 495.81 k USD. The greatest contribution to the revenue figure was made by United States and Australia — last year it brought TFF Pharmaceuticals, Inc. 733.87 k USD, and the year before that — 495.81 k USD.